DGX - Quest Diagnostics
153.10
| Index: | S&P 500 | P/E: | 20.55 | EPS (ttm): | 7.45 | Insider Own: | 0.50% | Shs Outstand: | 112.00M | Perf Week: | -1.23% |
| Market Cap: | 17.27B | Forward P/E: | 15.74 | EPS next Y: | 9.73 | Insider Trans: | -18.00% | Shs Float: | 111.06M | Perf Month: | -5.10% |
| Income(ttm): | 838.00M | PEG: | 3.11 | EPS next Q: | 2.19 | Inst Own: | 89.56% | Short Float: | 1.84% | Perf Quarter: | -0.57% |
| Revenue(ttm): | 9.54B | P/S: | 1.81 | EPS this Y: | 2.17% | Inst Trans: | 0.40% | Short Ratio: | 2.43 | Perf Half Y: | 9.18% |
| Book/sh: | 60.79 | P/B: | 2.52 | EPS next Y: | 9.32% | ROA: | 5.67% | Short Interest: | 2.04M | Perf Year: | 13.60% |
| Cash/sh: | 6.77 | P/C: | 22.60 | EPS next 5Y: | 6.60% | ROE: | 12.66% | 52W Range: | 123.04 - 165.32 | Perf YTD: | 11.04% |
| Dividend Est.: | 2.92 (1.91%) | P/FCF: | 16.88 | EPS past 5Y: | 7.36% | ROI: | 6.45% | 52W High: | -7.39% | Beta: | 0.90 |
| Dividend TTM: | 2.96 (1.93%) | Quick Ratio: | 1.17 | Sales past 5Y: | 4.86% | Gross Margin: | 31.74% | 52W Low: | 24.43% | ATR (14): | 3.07 |
| Dividend Ex-Date: | Jan 14, 2025 | Current Ratio: | 1.25 | EPS Y/Y TTM: | 11.04% | Oper. Margin: | 14.15% | RSI (14): | 40.84 | Volatility: | 2.41% 1.78% |
| Employees: | 48000 | Debt/Eq: | 1.02 | Sales Y/Y TTM: | 2.60% | Profit Margin: | 8.78% | Recom: | 2.05 | Target Price: | 172.93 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.91 | EPS Q/Q: | 1.79% | Payout: | 37.76% | Rel Volume: | 1.60 | Prev Close: | 151.52 |
| Sales Surprise: | 2.39% | EPS Surprise: | 1.60% | Sales Q/Q: | 8.41% | Earnings: | Oct 22 BMO | Avg Volume: | 840.28K | Price: | 153.10 |
| SMA20: | -3.14% | SMA50: | -2.31% | SMA200: | 5.00% | Undervalued: 12.95% | Volume: | 1,344,317 | Change: | 1.04% | |
Graham Classic formula value: 145.17
(P/E=8 * 1g) Min value: 97.67
(current P/E * 2g) Max value: 225.78
Average value: 156.21
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.